Cargando…

Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications

We have recently described manufacturing of human induced pluripotent stem cells (iPSC) master cell banks (MCB) generated by a clinically compliant process using cord blood as a starting material (Baghbaderani et al. in Stem Cell Reports, 5(4), 647–659, 2015). In this manuscript, we describe the det...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baghbaderani, Behnam Ahmadian, Syama, Adhikarla, Sivapatham, Renuka, Pei, Ying, Mukherjee, Odity, Fellner, Thomas, Zeng, Xianmin, Rao, Mahendra S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919381/ https://www.ncbi.nlm.nih.gov/pubmed/27283945 http://dx.doi.org/10.1007/s12015-016-9662-8

Ejemplares similares

Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers
por: Shafa, Mehdi, et al.
Publicado: (2018)

cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications
por: Baghbaderani, Behnam Ahmadian, et al.
Publicado: (2015)

Genotoxic Effects of Culture Media on Human Pluripotent Stem Cells
por: Prakash Bangalore, Megha, et al.
Publicado: (2017)

Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson’s Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations
por: Momcilovic, Olga, et al.
Publicado: (2016)

A platform for rapid generation of single and multiplexed reporters in human iPSC lines
por: Pei, Ying, et al.
Publicado: (2015)

A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem Cells
por: Ahmadian Baghbaderani, Behnam, et al.
Publicado: (2016)

Mitochondrial Alterations by PARKIN in Dopaminergic Neurons Using PARK2 Patient-Specific and PARK2 Knockout Isogenic iPSC Lines
por: Shaltouki, Atossa, et al.
Publicado: (2015)

Computational fluid dynamics modeling, a novel, and effective approach for developing scalable cell therapy manufacturing processes
por: Shafa, Mehdi, et al.
Publicado: (2019)

Characterization of human induced pluripotent stems cells: Current approaches, challenges, and future solutions
por: Suresh Babu, Sahana, et al.
Publicado: (2023)

Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells
por: Shafa, Mehdi, et al.
Publicado: (2019)

Generation of Transplantable Retinal Photoreceptors from a Current Good Manufacturing Practice‐Manufactured Human Induced Pluripotent Stem Cell Line
por: Zhu, Jie, et al.
Publicado: (2017)

Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells Under Defined Conditions
por: Swistowski, Andrzej, et al.
Publicado: (2010)

A Method to Identify and Isolate Pluripotent Human Stem Cells and Mouse Epiblast Stem Cells Using Lipid Body-Associated Retinyl Ester Fluorescence
por: Muthusamy, Thangaselvam, et al.
Publicado: (2014)

A Method to Identify and Isolate Pluripotent Human Stem Cells and Mouse Epiblast Stem Cells Using Lipid Body-Associated Retinyl Ester Fluorescence
por: Muthusamy, Thangaselvam, et al.
Publicado: (2016)

Pluripotent stem cells for Parkinson's disease: progress and challenges
por: Zeng, Xianmin, et al.
Publicado: (2013)

The role of induced pluripotent stem cells in regenerative medicine: neurodegenerative diseases
por: Peng, Jun, et al.
Publicado: (2011)

Distributed automated manufacturing of pluripotent stem cell products
por: Shariatzadeh, Maryam, et al.
Publicado: (2019)

Advances in Induced Pluripotent Stem Cell Technologies
por: Pal, Rajarshi, et al.
Publicado: (2012)

INDEX-db: The Indian Exome Reference Database (Phase I)
por: Ahmed P, Husayn, et al.
Publicado: (2019)

Generation and characterization of individual-specific induced pluripotent cells from patient-derived lymphoblastoid cell lines
por: Zulfiqar, Shadaan, et al.
Publicado: (2013)

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models
por: Spathopoulou, Angeliki, et al.
Publicado: (2022)

Scalable Passaging of Adherent Human Pluripotent Stem Cells
por: Nie, Ying, et al.
Publicado: (2014)

End-to-End Platform for Human Pluripotent Stem Cell Manufacturing
por: Pandey, Puspa R., et al.
Publicado: (2019)

Xeno-Free Defined Conditions for Culture of Human Embryonic Stem Cells, Neural Stem Cells and Dopaminergic Neurons Derived from Them
por: Swistowski, Andrzej, et al.
Publicado: (2009)

DNA Repair in Human Pluripotent Stem Cells Is Distinct from That in Non-Pluripotent Human Cells
por: Luo, Li Z., et al.
Publicado: (2012)

Heparin Promotes Cardiac Differentiation of Human Pluripotent Stem Cells in Chemically Defined Albumin‐Free Medium, Enabling Consistent Manufacture of Cardiomyocytes
por: Lin, Yongshun, et al.
Publicado: (2016)

Correction: DNA Repair in Human Pluripotent Stem Cells Is Distinct from That in Non-Pluripotent Human Cells
por: Luo, Li Z., et al.
Publicado: (2012)

Correction: DNA Repair in Human Pluripotent Stem Cells Is Distinct from That in Non-Pluripotent Human Cells
por: Luo, Li Z., et al.
Publicado: (2012)

Correction: DNA Repair in Human Pluripotent Stem Cells Is Distinct from That in Non-Pluripotent Human Cells
por: Luo, Li Z., et al.
Publicado: (2012)

Evaluating epistatic interaction signals in complex traits using quantitative traits
por: Mukherjee, Odity, et al.
Publicado: (2009)

Novel Live Alkaline Phosphatase Substrate for Identification of Pluripotent Stem Cells
por: Singh, Upinder, et al.
Publicado: (2012)

Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
por: Lee, Brian, et al.
Publicado: (2020)

Downstream bioprocessing of human pluripotent stem cell‐derived therapeutics
por: Sart, Sebastien, et al.
Publicado: (2021)

Exome sequencing in families with severe mental illness identifies novel and rare variants in genes implicated in Mendelian neuropsychiatric syndromes
por: Ganesh, Suhas, et al.
Publicado: (2018)

Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
por: Shankar, Keerthana, et al.
Publicado: (2020)

Manufacturing with pluripotent stem cells (PSConf 2021): Key issues for future research and development
por: Stacey, Glyn N., et al.
Publicado: (2022)

Manufacturing Cells for Clinical Use
por: Weiss, Mark L., et al.
Publicado: (2016)

Detailed characterization of the mouse embryonic stem cell transcriptome reveals novel genes and intergenic splicing associated with pluripotency
por: Kunarso, Galih, et al.
Publicado: (2008)

Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application
por: Kitano, Yuko, et al.
Publicado: (2022)

A review on the therapeutic potential of embryonic and induced pluripotent stem cells in hepatic repair
por: Krishna, K. Ananda, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ajapgj45mv9ersno4v67jemdv8